← Research library

Identification of short peptides: optimization of target therapeutic properties of the thymus medicine

Laboratory analysis · 2021

What was studied
Thymalin composition by UHPLC–MS
Main finding
Identifies KE and EDP as minor components of Thymalin and cites earlier detection of EW. KE maps to Vilon; EW maps to Thymogen in the short-peptide catalogue.

Study data at a glance

Participants or experimental model
Thymalin composition by UHPLC–MS
Reported results
Identifies KE and EDP as minor components of Thymalin and cites earlier detection of EW. KE maps to Vilon; EW maps to Thymogen in the short-peptide catalogue.
Study limitations and source details

Study limitations

  • EW identification is cited earlier work, not a new EW experiment in this report.
  • Presence in the extract does not assign all extract benefits to individual sequences.

Source details

Publisher English abstract and reference list checked.

Sources checked

Citation

Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences · Institute of Toxicology, Federal Medical-Biological Agency

Analytical / composition studyEnglish abstract

V. Kh. Khavinson, I. K. Zhurkovich, G. A. Ryzhak, E. S. Mironova, N. G. Kovrov. Identification of short peptides: optimization of target therapeutic properties of the thymus medicine Molecular Medicine, 2021

Study source ↗ · DOI 10.29296/24999490-2021-03-05 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards